HEATHER TRESIDDER: Open Payments
NPI 1184323917 · BOISE, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$298 in 9 payments from 9 companies in 2025. Trend: 2023 $125 · 2024 $355 · 2025 $298
Food & beverage: $298
| Company | Payments | Amount |
|---|---|---|
| MERZ NORTH AMERICA, INC. | 1 | $94 |
| ABBVIE INC. | 1 | $64 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $26 |
| Viatris Specialty LLC | 1 | $24 |
| REVANCE THERAPEUTICS, INC. | 1 | $23 |
| AstraZeneca Pharmaceuticals LP | 1 | $19 |
| GENZYME CORPORATION | 1 | $17 |
| GlaxoSmithKline, LLC. | 1 | $16 |
| Novartis Pharmaceuticals Corporation | 1 | $16 |
Products named: BOTOX, OFEV, YUPELRI, DAXXIFY, TEZSPIRE, DUPIXENT, NUCALA, XOLAIR.
Industry payments across ID — which companies pay providers there.
